Stockreport

ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives

ProPhase Labs, Inc.  (PRPH) 
US:NASDAQ Investor Relations: prophaselabs.com/investors/annual-reports
PDF Nebula Genomics secures major international B2B deal – Additional significant B2B deals in final stages Ahead of schedule, Pharmaloz Manufacturing accelerates cap [Read more]